Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 8,279 shares at $91.96 ($764K) on 2017-03-16, disclosed to the SEC on 2017-03-17.
Seasonal sale ($764k) by EVP, Chief Financial Officer — this insider has traded BMRN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.50 | 4,301 | $398K | 52.1% |
| 2 | $91.96 | 1,989 | $183K | 24.0% |
| 3 | $91.96 | 1,989 | $183K | 24.0% |
| Total | $92.24 avg | 8,279 | $764K | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |